Synergetics to be acquired by Valeant Pharmaceuticals
Permalink

Synergetics to be acquired by Valeant Pharmaceuticals

Valeant Profit Beats Estimates As U.S. Sales Stay Strong
Permalink

Valeant Profit Beats Estimates As U.S. Sales Stay Strong

In a research note issued to investors, span class=”tipranks-expert-name”> Chris Schott at J.P. Morgan Reiterated…

Continue Reading →